Evidence map›Paper›PMID 26180790›Full record

Trial reportBioMed research international2015

HPV Testing from Dried Urine Spots as a Tool for Cervical Cancer Screening in Low-Income Countries.

Elena Rosanna Frati, Marianna Martinelli, Ester Fasoli, Daniela Colzani, Silvia Bianchi, Sandro Binda, Pierfranco Olivani, Elisabetta Tanzi

Abstract readClinical Trial
In one paragraph

Trial report in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Analysis of Human Papillomavirus (HPV) 16 Variants Associated with Cervical Infection in Italian Women.International journal of environmental research and public health · 2020
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Elena Rosanna FratiDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Marianna MartinelliDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Ester FasoliDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Daniela ColzaniDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Silvia BianchiDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Sandro BindaDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.
Pierfranco OlivaniNAGA Onlus, 20136 Milan, Italy.
Elisabetta TanziDepartment of Biomedical Sciences for Health, University of Milan, 20133 Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, several screening strategies are available to prevent cervical cancer, but inadequate resources, sociocultural barriers, and sampling issues impede their success in low-income countries. To overcome these issues, this study aimed to evaluate the performance of human papillomavirus (HPV) testing from dried urine spots (DUS). Eighty-eight urine samples (including 56 HPV DNA positive specimens) were spotted on filter paper, dried, and stored in paper-bags. HPV DNA was detected from the DUS after 1 week and 4 weeks of storage using a polymerase chain reaction (PCR) assay. The sensitivity, specificity, and concordance of the DUS-based HPV test were evaluated by comparing the results with those of HPV testing on fresh urine samples as the gold standard. The sensitivity of the test was 98.21% (95% CI: 90.56-99.68) for DUS stored for 1 week and 96.42% (95% CI: 87.88-99.01) for DUS stored for 4 weeks. The specificity was 100% (95% CI: 89.28-100) at both time points. The concordance between DUS and fresh urine HPV testing was "almost perfect" using the κ statistic. These preliminary data suggest that a DUS-based assay could bypass sociocultural barriers and sampling issues and therefore could be a suitable, effective tool for epidemiological surveillance and screening programs, especially in low-income countries.

Indexed as

AlphapapillomavirusMass ScreeningAdultDeveloping CountriesDNA, ViralFemaleHumansPapillomavirus InfectionsPolymerase Chain ReactionUrineUterine Cervical NeoplasmsDNA, Viral

Identifiers

PMID26180790
PMCPMC4477205

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.